These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 17593365

  • 1. Prostaglandin E(2) receptors in bone formation.
    Li M, Thompson DD, Paralkar VM.
    Int Orthop; 2007 Dec; 31(6):767-72. PubMed ID: 17593365
    [Abstract] [Full Text] [Related]

  • 2. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.
    Suzawa T, Miyaura C, Inada M, Maruyama T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Suda T.
    Endocrinology; 2000 Apr; 141(4):1554-9. PubMed ID: 10746663
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: In vivo and in vitro evidence.
    Graham S, Gamie Z, Polyzois I, Narvani AA, Tzafetta K, Tsiridis E, Helioti M, Mantalaris A, Tsiridis E.
    Expert Opin Investig Drugs; 2009 Jun; 18(6):746-66. PubMed ID: 19426119
    [Abstract] [Full Text] [Related]

  • 4. Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves.
    Kopp UC, Cicha MZ, Nakamura K, Nüsing RM, Smith LA, Hökfelt T.
    Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1269-82. PubMed ID: 15292051
    [Abstract] [Full Text] [Related]

  • 5. Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure.
    Echeverria V, Clerman A, Doré S.
    Eur J Neurosci; 2005 Nov; 22(9):2199-206. PubMed ID: 16262658
    [Abstract] [Full Text] [Related]

  • 6. Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice.
    Miyaura C, Inada M, Suzawa T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Suda T.
    J Biol Chem; 2000 Jun 30; 275(26):19819-23. PubMed ID: 10749873
    [Abstract] [Full Text] [Related]

  • 7. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4.
    Chun KS, Akunda JK, Langenbach R.
    Cancer Res; 2007 Mar 01; 67(5):2015-21. PubMed ID: 17332329
    [Abstract] [Full Text] [Related]

  • 8. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
    Iwanaga K, Okada M, Murata T, Hori M, Ozaki H.
    J Pharmacol Exp Ther; 2012 Mar 01; 340(3):604-11. PubMed ID: 22138372
    [Abstract] [Full Text] [Related]

  • 9. [Role of EP4 receptor in bone resorption induced by PGE].
    Miyaura C.
    Nihon Yakurigaku Zasshi; 2001 Apr 01; 117(4):293-7. PubMed ID: 11338379
    [Abstract] [Full Text] [Related]

  • 10. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
    Matsumoto S, Ikeda M, Yoshida S, Tanimoto T, Takeda M, Nasu M.
    Br J Pharmacol; 2005 Jun 01; 145(4):503-13. PubMed ID: 15821755
    [Abstract] [Full Text] [Related]

  • 11. Role of EP2 and EP4 receptor-selective agonists of prostaglandin E(2) in acute and chronic kidney failure.
    Vukicevic S, Simic P, Borovecki F, Grgurevic L, Rogic D, Orlic I, Grasser WA, Thompson DD, Paralkar VM.
    Kidney Int; 2006 Sep 01; 70(6):1099-106. PubMed ID: 16871242
    [Abstract] [Full Text] [Related]

  • 12. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
    Noguchi K, Iwasaki K, Shitashige M, Endo H, Kondo H, Ishikawa I.
    J Dent Res; 2000 Dec 01; 79(12):1955-61. PubMed ID: 11201045
    [Abstract] [Full Text] [Related]

  • 13. EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures.
    Minamizaki T, Yoshiko Y, Kozai K, Aubin JE, Maeda N.
    Bone; 2009 Jun 01; 44(6):1177-85. PubMed ID: 19233324
    [Abstract] [Full Text] [Related]

  • 14. Modulation of ocular inflammatory responses by EP1 receptors in mice.
    Biswas S, Bhattacherjee P, Paterson CA, Maruyama T, Narumiya S.
    Exp Eye Res; 2007 Jan 01; 84(1):39-43. PubMed ID: 17052707
    [Abstract] [Full Text] [Related]

  • 15. Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells.
    Friis UG, Stubbe J, Uhrenholt TR, Svenningsen P, Nüsing RM, Skøtt O, Jensen BL.
    Am J Physiol Renal Physiol; 2005 Nov 01; 289(5):F989-97. PubMed ID: 15985651
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.
    Schweda F, Klar J, Narumiya S, Nüsing RM, Kurtz A.
    Am J Physiol Renal Physiol; 2004 Sep 01; 287(3):F427-33. PubMed ID: 15113745
    [Abstract] [Full Text] [Related]

  • 17. Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.
    Li YJ, Wang XQ, Sato T, Kanaji N, Nakanishi M, Kim M, Michalski J, Nelson AJ, Sun JH, Farid M, Basma H, Patil A, Toews ML, Liu X, Rennard SI.
    Am J Respir Cell Mol Biol; 2011 Jan 01; 44(1):99-107. PubMed ID: 20203295
    [Abstract] [Full Text] [Related]

  • 18. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse.
    Nataraj C, Thomas DW, Tilley SL, Nguyen MT, Mannon R, Koller BH, Coffman TM.
    J Clin Invest; 2001 Oct 01; 108(8):1229-35. PubMed ID: 11602631
    [Abstract] [Full Text] [Related]

  • 19. The effect of deletion of cyclooxygenase-2, prostaglandin receptor EP2, or EP4 in bone marrow cells on osteoclasts induced by mouse mammary cancer cell lines.
    Ono K, Akatsu T, Kugai N, Pilbeam CC, Raisz LG.
    Bone; 2003 Nov 01; 33(5):798-804. PubMed ID: 14623055
    [Abstract] [Full Text] [Related]

  • 20. Crucial involvement of the EP4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines and lipopolysaccharide.
    Sakuma Y, Tanaka K, Suda M, Yasoda A, Natsui K, Tanaka I, Ushikubi F, Narumiya S, Segi E, Sugimoto Y, Ichikawa A, Nakao K.
    J Bone Miner Res; 2000 Feb 01; 15(2):218-27. PubMed ID: 10703923
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.